US-based data management company Liaison Technologies has met the milestones needed to secure a $30m investment from US-based pharmaceutical company Merck’s Global Health Innovation Fund on April 10.
Liaison originally said in October last year it had secured an investment of up to $30m.
Liaison said its healthcare and life sciences division has grown revenues by an average of 40% annually in each of the past four years. Liaison was founded in 2000.